By Kelly Franchetti, Senior Vice President, Global Head Patient Insights and Strategy, YPrime
Patient-centered drug development is the name of the game. Technology solutions help to broaden opportunities for patients to participate in clinical studies, help sponsors and sites monitor the patients’ progress in real time and help maintain scientific rigor in the data collection process. The industry is aware that deep insights are required to develop patient-focused protocols, trial designs, enrollment, retention strategies and shared decision-making tools. How much do we really know about the burden of disease, how patients experience their diagnostic and treatment journey, and what factors influence their health behaviors and decision-making process? And where do we get that information?